CDRH Scientists Need To Focus On Regulatory Mission, Advertise Successes – Science Board Report
This article was originally published in The Gray Sheet
Executive Summary
Investment in CDRH regulatory science is “non-negotiable,” but the center’s efforts need to be appropriately focused, and it should do a better job of measuring and communicating success, an FDA Science Advisory Board Subcommittee report finds.